Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Chevallier

Showing results (151-160 of 184) with videos related to

Pageof 19
Sort By:
European Journal of Ophthalmology|October 1, 1992
Influence of carteolol and timolol on IOP an visual fields in glaucoma: a multi-center, double-masked, prospective studyJ Flammer, Y Kitazawa, L Bonomi, et al.
Revue Medicale De La Suisse Romande|May 1, 1986
[New options concerning the management of the hearing-impaired child]M Bachmann, B Chevallier, C Clément, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 1998
Results of a phase II trial with second-line cystemustine at 60 mg/m2 in advanced soft tissue sarcoma: a trial of the EORTC Early Clinical Studies GroupH Curé, I Krakowski, A Adenis, et al.
British Journal of Cancer|March 1, 1993
The Centre H. Becquerel studies in inflammatory non metastatic breast cancer. Combined modality approach in 178 patientsB Chevallier, P Bastit, Y Graic, et al.
American Journal of Clinical Oncology|June 11, 1999
Phase I-II trial of intensification of the MAID regimen with support of lenograstim (rHuG-CSF) in patients with advanced soft-tissue sarcoma (STS)C Chevreau, B N Bui, B Chevallier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Lenograstim prevents morbidity from intensive induction chemotherapy in the treatment of inflammatory breast cancerB Chevallier, P Chollet, Y Merrouche, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase II study of pirarubicin (THP) in patients with cervical, endometrial and ovarian cancer: study of the Clinical Screening Group of the European Organization for Research and Treatment of Cancer (EORTC)J Chauvergne, P Fumoleau, P Cappelaere, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|August 22, 2006
[Influenza vaccination coverage rate in children with underlying chronic disorders in 7 French pediatric wards]C Weil-Olivier, F Angoulvant, B Chevallier, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|December 5, 2002
[Risk factors for early bronchiolitis at asthma during childhood: case-control study of asthmatics aged 4 to 12 years]D Ploin, P Foucaud, J P Lemaire, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of CancerB Chevallier, P Fumoleau, P Kerbrat, et al.
Pageof 19

Showing results (151-160 of 184) with videos related to

Sort By:
Pageof 19
European Journal of Ophthalmology|October 1, 1992
Influence of carteolol and timolol on IOP an visual fields in glaucoma: a multi-center, double-masked, prospective studyJ Flammer, Y Kitazawa, L Bonomi, et al.
Revue Medicale De La Suisse Romande|May 1, 1986
[New options concerning the management of the hearing-impaired child]M Bachmann, B Chevallier, C Clément, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 1998
Results of a phase II trial with second-line cystemustine at 60 mg/m2 in advanced soft tissue sarcoma: a trial of the EORTC Early Clinical Studies GroupH Curé, I Krakowski, A Adenis, et al.
British Journal of Cancer|March 1, 1993
The Centre H. Becquerel studies in inflammatory non metastatic breast cancer. Combined modality approach in 178 patientsB Chevallier, P Bastit, Y Graic, et al.
American Journal of Clinical Oncology|June 11, 1999
Phase I-II trial of intensification of the MAID regimen with support of lenograstim (rHuG-CSF) in patients with advanced soft-tissue sarcoma (STS)C Chevreau, B N Bui, B Chevallier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Lenograstim prevents morbidity from intensive induction chemotherapy in the treatment of inflammatory breast cancerB Chevallier, P Chollet, Y Merrouche, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase II study of pirarubicin (THP) in patients with cervical, endometrial and ovarian cancer: study of the Clinical Screening Group of the European Organization for Research and Treatment of Cancer (EORTC)J Chauvergne, P Fumoleau, P Cappelaere, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|August 22, 2006
[Influenza vaccination coverage rate in children with underlying chronic disorders in 7 French pediatric wards]C Weil-Olivier, F Angoulvant, B Chevallier, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|December 5, 2002
[Risk factors for early bronchiolitis at asthma during childhood: case-control study of asthmatics aged 4 to 12 years]D Ploin, P Foucaud, J P Lemaire, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of CancerB Chevallier, P Fumoleau, P Kerbrat, et al.
Pageof 19